AI content at scale without wrecking medical accuracy

Last reviewed 24 October 2026

AI medical content for hospitals works only when a structured, clinician-approved fact base is separated from the prose a model generates around it, so scale never outruns accuracy. The article sets out the tiered review, templates and automated checks that let a small team publish thousands of defensible pages.

Updated 24 October 2026: merged in our guide on reviewing AI-generated doctor content, and added the review line for doctor-bylined, translated and synthetic content.

See every AI in healthcare operations guide in one place.

A hospital group with fifty units, a few thousand doctors and several hundred procedures needs tens of thousands of web pages to be present in search for what it actually does. No content team can write that by hand at acceptable cost. AI can. The question is not whether to use it. The question is how to use it without publishing something a clinician would refuse to sign, in a market where a single wrong sentence about a drug interaction or a procedure risk reaches a family who will act on it.

This is the operating model that lets a hospital group produce medical content at scale while keeping every published claim defensible.

What are the two failure modes of AI medical content?

Groups fail in one of two directions.

Reckless scale. A vendor or an internal team points a language model at a list of conditions and procedures, generates thousands of pages, and publishes them with a generic disclaimer. The pages are fluent, plausible and periodically wrong. Nobody with a medical licence has read them. The first time a patient or a journalist finds an error, the group’s entire content programme becomes a liability, and the search engines, which increasingly evaluate medical content for expertise and authorship, quietly stop ranking it.

Paralysed caution. The medical director insists that every page be written by a clinician and reviewed by a second. Output is a handful of pages a month. The doctor-directory pages stay thin, the procedure pages stay generic, and the group is invisible for the long tail of queries that actually bring patients.

The model that works sits between these: AI drafts at scale inside a controlled structure, and human medical review is concentrated where it matters and made fast enough to keep up.

Principle 1: Separate facts from prose

Most medical content risk lives in a small number of factual claims: indications, contraindications, risks, recovery timelines, drug names, dosages, costs. The surrounding prose, the explanation of what a procedure is and why someone might need it, is low-risk if it is built from approved facts.

So build a structured fact base first. For each procedure, condition and service line, a clinician-approved record of the claims the group is willing to make: what it is, who it is for, what the alternatives are, the typical hospital stay, the typical recovery, the known risks in plain language, the price range if the group publishes one. This is a database, not a document. It is reviewed once by the relevant specialty lead and versioned.

AI then generates pages from the fact base, not from its own training. The prompt provides the approved facts and instructs the model to explain them, not to add to them. This single design choice removes most of the hallucination risk before a reviewer ever sees a draft.

Principle 2: Template the structure so review is fast

A reviewer reading a free-form article has to check everything. A reviewer reading a page built on a fixed template knows exactly where the claims are and can check them in minutes. Every content type gets a template: procedure page, condition page, doctor profile, FAQ, pre-visit guide, post-discharge guide. The template fixes which sections exist, which sections may contain medical claims, and which sections are explanatory only.

Reviewers then review the claim-bearing sections against the fact base and skim the rest. Review time per page drops from an hour to minutes, which is the difference between a programme that scales and one that dies in the approval queue.

Principle 3: Tier the review by risk

Not every page needs the same scrutiny.

• Tier 1, full clinical review: anything describing risks, medication, dosing, emergency guidance, paediatric or obstetric content, oncology treatment pathways. A named specialist signs off and is credited as the reviewer on the page.
• Tier 2, specialty spot-check: procedure and condition explainers built strictly from the approved fact base. A specialty lead reviews a sample each week and the fact base itself; individual pages go live on the strength of the template and the fact base.
• Tier 3, editorial review only: logistics, hospital information, doctor biographies drawn from HR data, navigation content. A medical writer or editor checks accuracy against source data; no clinician time is spent.

Publishing the review tier and the reviewer’s name on the page is not just a compliance measure. It is what search engines and AI assistants look for when deciding whether medical content is trustworthy.

Principle 4: Constrain the model, then test it

The generation prompt carries hard rules: use only the provided facts, do not state numbers not in the facts, do not name drugs not in the facts, do not make comparative or superlative claims, flag any gap rather than fill it. The output is then run through automated checks before a human sees it:

• Every number and drug name in the output must appear in the fact base
• Banned phrases and superlatives are detected and rejected
• Reading level is checked against the target audience
• Required sections are present; forbidden sections are absent

Pages that fail any check go back to generation, not to a reviewer. Human attention is spent only on pages that have already passed the machine checks.

Principle 5: Regional language is a review problem, not a translation problem

Translating approved English content into Hindi, Telugu, Tamil, Bengali or Kannada is now cheap and reasonably good. The bottleneck is a clinician who reads the target language and can confirm that the medical meaning survived. Solve it by scope: translate the highest-volume pages per unit first, route them to unit clinicians who read that language, and treat the review as a comparison against an already-approved English source rather than a fresh clinical review. Publish with proper language tagging so search engines serve the right version.

One trap deserves its own rule. A doctor approves an English article, the team produces Hindi, Marathi, Tamil or Bengali versions with an AI assistant, and publishes them under the same byline on the assumption that approval carries over. It does not. A translated article is new text: medical terms shift, cautious phrasing can become confident, and a careful sentence in English can read as a promise in another language. Every language version under a doctor’s name needs a clinically literate reviewer who reads that language fluently, ideally from the same department, and the named doctor should know which languages their content appears in. Where no such reviewer exists, publish the regional version as hospital content rather than under the doctor’s name.

For the next step, see Using AI to triage enquiries without making clinical calls, Putting an AI agent in front of patients without an incident and Building location pages without thin content.

Principle 6: Keep it alive

Medical content decays. Guidelines change, doctors leave, prices move, a procedure is discontinued. The fact base needs an owner per specialty and a review cadence. When a fact changes, every page generated from it is regenerated and re-reviewed at the appropriate tier. This is only possible because the pages were generated from structured facts in the first place; a library of hand-written articles cannot be updated this way, which is why so many hospital sites carry years-old content nobody dares touch.

The Indian specifics

Advertising rules. Indian regulations on medical advertising restrict claims of superiority, guaranteed outcomes and certain kinds of solicitation. Encode these as banned patterns in the automated checks so that no page can pass with them.

Doctor consent. Content published under a doctor’s name, or featuring a doctor as reviewer, requires their agreement. Build the consent into onboarding and store it. Do not discover the absence of consent when a doctor resigns and asks for their name to be removed from three hundred pages.

Price transparency. If the group publishes indicative prices, the fact base must hold them and the pages must show the date. Stale prices are a patient-trust problem and, increasingly, a regulatory one.

Aggregator scraping. Doctor-directory and hospital-listing platforms will republish your content in fragments. Consistent, accurate, structured content on your own site makes their version more accurate too. Inaccurate content on your site propagates.

When content carries a doctor’s name: where the review line sits

Everything above is about the hospital’s own voice: condition pages, service explainers, FAQs. Content published under a named doctor raises a further set of problems on top of accuracy, and the rules need to be stricter than most teams would like. A doctor’s name on a piece of content is a personal promise that this specific person, with their training and registration, stands behind these words. AI quietly thins that promise: drafts appear faster than doctors can read them, a model can write in a doctor’s style from past articles, and it can now produce the video too, with a synthetic face and voice.

Why doctor content is a different category

• Attribution. When content is published as the hospital, the hospital is accountable. When it is published as a named doctor, that doctor’s professional reputation and standing with peers and the regulator are on the line. A doctor who did not really write or approve what appears under their name has been put at risk by the marketing team.
• Trust. Patients read a doctor’s article as personal expertise and personal judgement. If that assumption is false, the content is misleading even when every fact in it is correct.
• Identity. Synthetic voice and video create a reusable likeness of a person. It can outlive the doctor’s time at the hospital, be used in contexts they never saw and be copied by others.

Review requirements by type of doctor content

A single rule for everything is either too loose or too heavy to follow. I sort doctor content by two questions: how much it says about clinical matters, and how directly it represents the doctor as a person.

The line for educational content

• The named doctor approves the final form. Not the outline, not an earlier draft: the final text or the final cut of the video. A doctor approving an outline and then finding a different version live is the most common way this goes wrong.
• Clinical claims get a second clinical reviewer. Anything that makes a clinical claim, describes outcomes, compares treatments or mentions risks also goes to the head of department or someone the medical director nominates. Busy doctors skim fluent drafts; a reader who did not commission the piece catches what they miss.
• The draft starts from the doctor’s own input. An interview, notes, a recorded conversation or an article they already approved. A model writing “in the style of” a doctor on a topic they never discussed is not assistance. It is putting words in their mouth.
• The model may structure, not add. It can turn a rambling interview into a clear article, suggest headings, tighten sentences and propose social cut-downs. Any new factual sentence, statistic, outcome or recommendation is unverified until traced to the source or removed.
• The editor still owns everything non-clinical. Brand voice, claims about the hospital, legal compliance and consent for any patient references. Clinical approval does not replace editorial review; they check different things.

What the doctor is actually signing off

A quick “ok” on a messaging app between surgeries is not enough for AI-assisted content. I ask for a short, standard approval note that the doctor confirms: they have read the final version, the clinical content is accurate and within their own practice, they are comfortable with it appearing under their name, and where it will appear. For video, the approval covers the final edit, not the script. This protects the doctor as much as the hospital, because when a question is raised later both sides can see exactly what was approved. As I argue in the doctor as spokesperson, the doctor’s credibility is the asset, and marketing’s job is to protect it rather than spend it.

Synthetic voice and video: consent first

Tools can now produce a video of a doctor explaining a procedure in several languages from a single recording, or clone a voice for audio. The appeal for regional reach is obvious, so the rules need to be strict. Synthetic use of a doctor’s likeness or voice needs explicit, specific, written consent, separate from the employment contract and from general content approvals. The consent should say what will be generated, in which languages, for which channels, for how long, and what happens to the voice or face model when the doctor leaves. The doctor approves every final synthetic output, and the content says it has been generated or translated so patients are not misled.

Some uses I would refuse regardless of consent: a synthetic doctor answering individual patient questions in real time, a generated doctor persona replying to comments or messages, or anything that makes a patient believe they are getting personal advice from a real clinician when they are not. These cross from marketing into something that looks like clinical care, and no marketing team should own that.

Doctors’ own social accounts and ghostwriting

A doctor’s personal professional account belongs to the doctor. The hospital can offer drafting help, including AI-assisted drafts from the doctor’s own input, but the doctor posts or explicitly approves each post. Replies to patients on those accounts come from the doctor or not at all; a marketing executive using an AI assistant to answer a patient under a doctor’s name is where the grey zone becomes a real problem. Ghostwriting itself is not new or wrong. What AI changes is volume and distance, and the safeguard is the same as before: the doctor’s thinking is the source, and the doctor approves the result.

Who owns the doctor content policy

This policy cannot belong to marketing alone. It touches clinical governance, legal, HR and the doctors themselves. In my experience it works best when the medical director and the marketing head write it together and take it to the medical advisory committee or its equivalent, which is also the right forum to hear objections. There will be some, from doctors who want less friction and a few who want no AI involvement at all. Doctors accept rules they helped shape, the point of earning the right to change anything. HR needs to be in the room for one practical reason: when a doctor leaves, every piece of content in their name and any synthetic asset of their voice or face must be reviewed and usually retired, and that has to be triggered by the exit process, not left to marketing to notice months later.

Putting the doctor line in place

• Inventory. List everywhere doctor-attributed content appears: website, content hub, hospital-run social accounts, doctors’ own accounts that marketing helps with, video channels and WhatsApp broadcasts. Note which items were AI-assisted, if anyone knows.
• A two-page policy. Written with the medical director: the tiers, the review line for each, the approval note, synthetic media consent and the uses you will not allow. Take it to the doctors, adjust and get it formally approved.
• An approval log. The piece, channel, language, named doctor, second reviewer where needed, approval date and whether AI was used. A minute per piece saves hours the first time someone asks who approved a particular video.
• Apply it to what is live. Older content without a clear approval trail goes back to the doctor for review now, and anything they would not stand behind is retired.

Why the stakes are rising

Patients increasingly meet health information through AI tools, which raises the stakes for anything published under a doctor’s name.

• More than 230 million people ask health and wellness questions on ChatGPT each week, according to OpenAI, as reported by TechCrunch in January 2026.
• 32% of US adults used AI for health information and advice in the past year, and about eight in ten of those who had not said they trusted these tools not too much or not at all, according to the KFF Tracking Poll on Health Information and Trust, March 2026.
• Large language models tested on their own identified the relevant conditions in medical scenarios in 94.9% of cases, but when 1,298 members of the public used the same models, relevant conditions were identified in fewer than 34.5% of cases, according to Bean et al. in Nature Medicine, February 2026.

Every piece under a doctor’s name is either building trust in that doctor and the hospital or quietly borrowing against it. The review line is how you know which.

What the operating model looks like

1. A content product owner in the group digital team, accountable for the programme.
2. A specialty lead per service line who owns that specialty’s fact base and reviews Tier 1 pages.
3. Two or three medical writers who curate the fact base, manage templates, and handle Tier 3 review.
4. A generation pipeline with automated checks, feeding a review queue with tiers.
5. A publishing system that records reviewer, tier, date and fact-base version on every page.
6. A quarterly audit: a random sample of live pages re-reviewed against the current fact base, with error rates reported to the medical director.

With this in place, a small team can sustain a very large content estate with error rates lower than a hand-written library, because every claim traces back to an approved source and every change propagates automatically.

What the fact base actually contains

The fact base is the asset. Everything else is machinery. For a procedure, a complete record answers a fixed set of questions in plain language, each with the approving clinician and date:

• What the procedure is and what it treats
• Who it is suitable for and who it is not
• The main alternatives and when they are preferred
• How to prepare, including fasting, medication and tests
• What happens on the day and how long it takes
• Typical hospital stay and recovery milestones
• Known risks, stated as a patient would need to hear them
• Follow-up schedule and warning signs after discharge
• Which units offer it and which clinicians perform it
• Indicative cost range and what it includes, with a date

For a condition, the equivalent set covers symptoms, when to seek care, how it is diagnosed, treatment options, and what the group offers. For a doctor, the record is drawn from HR and credentialing data and reviewed by the doctor themselves.

Build this as structured data with an owner, a version and a change log, not as a shared document. The pages are derived from it; the search structured data is derived from it; the chatbot’s answers can be derived from it; the contact-centre knowledge base can be derived from it. One approved source, many outputs. This is the real return on the investment, and it compounds with every channel that reads from the same facts.

Measuring whether it is working

Three numbers on the content dashboard. Error rate from the quarterly audit, by tier and by specialty, trending down. Review turnaround time from generation to publication, by tier, trending toward days rather than weeks. And organic search visits to generated pages, by service line, with the enquiries they produce. If the first two are healthy and the third is growing, the programme is doing its job. If the third is growing and the first is not being measured, the programme is a liability waiting to be discovered.

If you’re setting this up next quarter

• Pick one service line and build its fact base first. Get the specialty lead to sign it.
• Build one template and one set of automated checks. Generate twenty pages. Have the specialty lead review them and report what the checks missed.
• Fix the checks, then scale that service line to full coverage before starting the next.
• Publish reviewer names and dates from the first page.
• Schedule the quarterly audit before you publish, not after the first complaint.

Scale and accuracy are not in tension when the facts are separated from the prose and the review is designed for speed. The groups that get this right will own the long tail of patient search in their markets. The ones that publish first and review later will spend years repairing the damage.

Further reading from primary sources

• Google Search Central: Creating helpful, reliable, people-first content: Google’s guidance on experience, expertise and trust.
• WHO: Ethics and governance of artificial intelligence for health (2021): global principles for accountable AI in health.
• ICMR: Ethical guidelines for AI in biomedical research and healthcare (2023): India’s guidance on responsible AI in healthcare.

Questions people ask

Also worth reading: Building a prompt library for a healthcare marketing team.